OncoOne is a biotech start-up dedicated to develop innovative therapeutics to treat patients with solid tumors, founded by three individuals with a long history in industrial drug development and oncology research.
The aim of OncoOne is to be a research engine for anti-cancer medicines that meet serious unmet medical needs in oncology. Our passion for science is at the core of everything we do to build a differentiated pipeline of potent therapeutics. Our entrepreneurial spirit enables us to link innovation with corporate strategies.
We are a team of experienced professionals.
Randolf Kerschbaumer, PhD
Founder & Chief Executive Officer
Randolf has more than 20 years of experience in academic and big pharma R&D and acquired detailed knowledge of the entire drug development process, from early drug screening to clinical development. He is in charge of executive management, fundraising, patenting and business development.
Michael Thiele, PhD
Founder & Chief Operating Officer
Michael is a renowned expert in immunology, tumor biology, biomarker and the development of biologics. He is responsible for establishing and managing external collaborations and our primary contact for our CROs and external partners.
Alexander Schinagl, PhD
Founder & Chief Scientific Officer
Alexander has a broad knowledge in molecular biology, biochemistry and cell biology techniques in the field of oncology and inflammation. He is responsible for lab management and continuously improves our in-house capabilities and technologies.